"The reported global prevalence of interstitial lung disease in patients diagnosed with idiopathic inflammatory myopathies is thought to be as high as 40% 1. Interstitial lung disease is a common extra-muscular manifestation of idiopathic inflammatory myopathies 3."
"antisynthetase antibodies: anti-Jo1, anti-PL-7, anti-PL-12, anti-EJ, anti-OJ, anti-KS, anti-Zo"
"antisynthetase antibodies: anti-Jo1, anti-PL-7, anti-PL-12, anti-EJ, anti-OJ, anti-KS, anti-Zo"
"antisynthetase antibodies: anti-Jo1, anti-PL-7, anti-PL-12, anti-EJ, anti-OJ, anti-KS, anti-Zo"
"antisynthetase antibodies: anti-Jo1, anti-PL-7, anti-PL-12, anti-EJ, anti-OJ, anti-KS, anti-Zo"
"antisynthetase antibodies: anti-Jo1, anti-PL-7, anti-PL-12, anti-EJ, anti-OJ, anti-KS, anti-Zo"
"anti-SRP"
"anti-fibrillarin (U3 RNP)"
"anti-Jo1 and anti-PL-7: non-specific interstitial pneumonia predominates; honeycombing is uncommon in anti-Jo1 2"
"anti-PL-12: organising pneumonia predominates 2"
"anti-OJ: usual interstitial pneumonia predominates, often with honeycombing 2"
"Myositis-associated interstitial lung disease refers to a group of interstitial lung diseases (ILD) that are associated with the presence of myositis-associated antibodies. This traditionally included dermatomyositis and polymyositis but can now include several other conditions (e.g. anti-Mi-2-positive interstitial lung disease)."
"antisynthetase antibodies: anti-Jo1, anti-PL-7, anti-PL-12, anti-EJ, anti-OJ, anti-KS, anti-Zo"
"Chest x-rays are often the initial investigation but are relatively insensitive to early disease; HRCT is the modality of choice for characterising pattern, distribution, and disease activity 5."
"anti-Jo1 and anti-PL-7: non-specific interstitial pneumonia predominates; honeycombing is uncommon in anti-Jo1 2"